Literature DB >> 104430

Pathological features of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine.

J P Sunter, D R Appleton, N A Wright, A J Watson.   

Abstract

The parenteral administration of 1,2-dimethylhydrazine to rats caused the development of colonic neoplasms in about 90% of animals by 24--30 weeks of treatment. Usually there were multiple tumours with a mean of 2.7 per rat. The lesions have been classified histologically into adenomata (26% of all tumours) and carcinomata, the latter showing varying degrees of differentiation. No completely anaplastic tumours were seen, and there were none originating in connective tissue. The distributions of the different tumour types along the length of the colon varied. The more benign lesions were situated predominantly in the distal half of the colon, while the poorly differentiated adenocarcinomata were concentrated in the proximal third of the colon. There was good evidence to suggest that adenomata often progressed to frank malignancy in the distal colon. In the proximal part, however, it appeared that tumours frequently developed de novo as poorly differentiated carcinomata. Perhaps regional variations in the kinetic organisation of the normal colonic mucosa somehow influence the nature of the neoplastic change induced by DMH, thus accounting for the differences in tumor distribution. After 24 weeks of DMH treatment there was only a small increase in the mean number of tumours per rat.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104430     DOI: 10.1007/bf02899354

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol


  21 in total

1.  Beta-endorphin cell therapy for cancer prevention.

Authors:  Changqing Zhang; Sengottuvelan Murugan; Nadka Boyadjieva; Shaima Jabbar; Pallavi Shrivastava; Dipak K Sarkar
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-17

2.  Are there diurnal fluctuations in crypt length and crypt cell birth rate in the intestines of normal and carcinogen-treated rats?

Authors:  P V Senior; J P Sunter; D R Appleton; A J Watson
Journal:  J Anat       Date:  1984-10       Impact factor: 2.610

3.  Development and cell kinetics of colonic tumors induced in mice by dimethylhydrazine.

Authors:  T Hattori; B Helpap; P Gedigk
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

4.  Are animal models of colon cancer relevant to human disease.

Authors:  D J Ahnen
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

5.  Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis.

Authors:  F Hallouin; C Goupille; M le Cabellec; J Bara; J le Pendu
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

6.  Experimental colonic carcinogenesis: changes in faecal bile acids after promotion of intestinal tumours by small bowel resection in the rat.

Authors:  A P Savage; M S Sian; J L Matthews; S R Bloom; T Cooke
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

7.  Three new rat colon tumour cell lines from 1,2-dimethylhydrazine induced adenocarcinomas: morphology, karyotype and clonogenicity.

Authors:  M A Maley; A K House; D J Jenkyn; M V Agrez
Journal:  Br J Exp Pathol       Date:  1987-10

8.  Enteroglucagon and experimental intestinal carcinogenesis in the rat.

Authors:  A P Savage; J L Matthews; M A Ghatei; T Cooke; S R Bloom
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

9.  Detection of early neoplastic changes in experimentally induced colorectal cancer using scanning electron microscopy and cell kinetic studies.

Authors:  T Cooke; N Kirkham; D H Stainthorp; C Inman; N Goeting; I Taylor
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

10.  Comparison of the significance of three histopathological thresholds of malignancy in experimental colorectal tumours.

Authors:  C Rowlatt; J P Cruse; T Barton; A A Sadrudin; M R Lewin
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.